PEROSA, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.893
EU - Europa 1.788
AS - Asia 720
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 4.409
Nazione #
US - Stati Uniti d'America 1.885
CN - Cina 557
IE - Irlanda 543
UA - Ucraina 418
IT - Italia 342
SE - Svezia 220
TR - Turchia 93
FI - Finlandia 91
FR - Francia 66
SG - Singapore 47
GB - Regno Unito 42
DE - Germania 23
IN - India 21
CZ - Repubblica Ceca 11
BE - Belgio 8
PL - Polonia 8
CA - Canada 7
RU - Federazione Russa 6
EU - Europa 3
NL - Olanda 3
SI - Slovenia 3
ES - Italia 2
A1 - Anonimo 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
IR - Iran 1
MC - Monaco 1
MX - Messico 1
MY - Malesia 1
Totale 4.409
Città #
Dublin 543
Chandler 386
Dearborn 302
Jacksonville 293
Nanjing 158
Nyköping 109
Nanchang 67
Beijing 62
Princeton 60
San Mateo 56
Wilmington 49
Helsinki 36
Ashburn 34
Ann Arbor 33
Kunming 33
Shenyang 33
Boardman 31
Singapore 31
Tianjin 30
Rome 25
Jiaxing 23
Milan 18
Changsha 16
Des Moines 15
Hebei 15
Woodbridge 14
Hangzhou 13
Brno 11
Changchun 10
Florence 9
Hilden 9
Ningbo 9
Bologna 8
Brussels 8
Jinan 8
Lanzhou 8
Los Angeles 8
Munich 8
Bari 7
Napoli 7
Radomsko 7
Shanghai 7
Zhengzhou 7
Catania 6
Guangzhou 6
New York 6
Norwalk 6
Hefei 5
Taizhou 5
Auburn Hills 4
Catanzaro 4
Chicago 4
Livorno 4
Peccioli 4
Reggio Calabria 4
Saint Petersburg 4
Sassari 4
Stevenage 4
Verona 4
Volla 4
Washington 4
Amsterdam 3
Bruino 3
Genoa 3
Koper 3
Leduc 3
Messina 3
Naples 3
Serra 3
Torino 3
Trieste 3
Villacidro 3
Wuhan 3
Abano Terme 2
Augusta 2
Brescia 2
Cagliari 2
Carlazzo 2
Chengdu 2
Como 2
Greenwich 2
Haikou 2
Jinhua 2
Lancenigo-Villorba 2
Latina 2
London 2
Lucca 2
Manchester 2
Margherita di Savoia 2
Marseille 2
Merano 2
Montesilvano Marina 2
Mountain View 2
Muravera 2
Omegna 2
Palermo 2
Palma Campania 2
Pavia 2
Piegaro 2
Redwood City 2
Totale 2.788
Nome #
Anticorpi anti-idiotipo 249
Anticorpi monoclonali anti-idiotipo (Ab2) anti-CD4 inducono anticorpi anti-CD4 in un sistema singenico 188
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 127
Purificazione delle Immunoglobuline 114
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 91
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 85
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 85
Studio funzionale e limiti terapeutici di anticorpi anti-idiotipo (Ab2) anti-CD4 nella infezione da HIV 82
Le vaccinazioni nei pazienti con immunodeficienza 82
SOLUBLE CD4 ANTIGEN REACTIVITY IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS: IS IT SPECIFIC? 80
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 79
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 79
Cloning and chromosomal localization of a cDNA encoding a mitochondrial porin from Drosophila melanogaster 79
L'isoelettrofocalizzazione nello studio delle gammapatie monoclonali 79
Caratteristiche ed indicazioni terapeutiche dei preparati di immunoglobuline umane 78
L'ospite immunocompromesso: un complesso sindromico in espansione. Quadri clinici, aspetti immunologici e prospettive terapeutiche 77
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 77
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 76
Uso di di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 75
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 73
Antiidiotypic monoclonal antibodies to anti HLA Class II monoclonal antibodies. Potential application in the treatment of autoimmune diseases 72
Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases 71
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 71
Immunoterapia: realta' e fantasia 71
Serological methods to detect anti-idiotypic antibodies 70
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 69
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 68
Monoclonal antibodies in the immunotherapy of autoimmune diseases 68
Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis 67
Mieloma multiplo e gammapatie monoclonali:quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 67
Subclass and clonotypic profiles of serum AB elicited with the "human CD4 internal AG" mab F16-16D7 (16D7) in 4 patients with systemic lupus erythematosus 67
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 66
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 66
Human immunoglobulins in therapy. Rationale and clinical applications 66
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 66
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti HLA-B7,B27 monoclonal antibodies 66
Anti-idiotypic monoclonal antibodies reacting with idiotope on isolated- denatured chains of an anti-CD4 monoclonal antibody 64
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 63
Soluble CD4 and commercial immunoglobulin 62
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 61
La difesa immunologica contro i tumori: dalla teoria alla clinica 61
BETA -MICROGLOBULIN-FREE HEAVY CHAIN FHC OF HLA CLASS I ANTIGEN IN PATIENTS WITH HODGKIN'S AND NON-HODGKIN'S LYMPHOMAS 60
CD4 mimicry by anti-idiotypic mAb (mAb2) F16-16D7 (16D7). Immunochemical and sequence analysis 60
Vasculiti primarie sistemiche 59
Syngeneic anti-idiotypic antisera to murine anti-HLA class II monoclonal antibodies 58
Immunogenicity of 2 Idiotopes with A Different Immunoglobulin- Chain Distribution Expressed on the Same Anti-Cd4-Mab 58
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 58
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 58
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 58
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 58
Studi in vitro dell'attivita' antiallergica del Fenoterolo 57
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 56
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 56
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 56
Le gammapatie monoclonali: moderno inquadramento diagnostico e prognostico 55
Le immunoglobuline in terapia: lo stato dell'arte 55
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 54
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 54
THU0164 Subclinical atherosclerosis and cardiovascular events in italian patients with rheumatoid arthritis: results from multicenter girrcs (gruppo italiano di ricerca in reumatologia clinica e sperimentale) study 42
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: Findings from a 3-year, multicentre, prospective, observational study 23
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 21
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 16
Dissecting the clinical heterogeneity of adult-onset Still's disease: Results from a multi-dimensional characterization and stratification 14
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 5
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 5
Totale 4.453
Categoria #
all - tutte 20.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020597 0 0 0 0 116 167 131 12 77 14 75 5
2020/2021497 67 4 63 5 69 62 70 23 63 69 2 0
2021/2022346 57 3 2 6 29 13 15 40 43 29 31 78
2022/20231.492 110 32 32 124 115 174 1 139 683 22 35 25
2023/2024207 33 17 19 19 29 34 1 22 0 5 2 26
2024/202586 36 1 15 26 8 0 0 0 0 0 0 0
Totale 4.453